论文部分内容阅读
抗高血糖药ｔｒｏｇｌｉｔａｚｏｎｅＷａｒｎｅｒ－Ｌａｎｂｅｒｔ／Ｓａｎｋｙｏ′ｓ的ｔｒｏｇｌｉｔａ－ｚｏｎｅ（Ｒｅｚｕｌｉｎ）已于１９９７年３月获美国ＦＤＡ批准，用于因产生耐受而单独使用胰岛素难控制的Ⅱ型糖尿病。这是第一个用于该类型糖尿病的口服抗高血...
The troglitazoneWarner-Lanbert / Sankyo’s antioglycan drug troglita-zone (Rezulin) was approved by the U.S. FDA in March 1997 for Type 2 diabetes, which is refractory to insulin alone due to tolerance. This is the first oral anti-hyperglycemia for this type of diabetes ...